Medical Research

Accelerate the development of effective therapies for Alzheimer’s and related neurodegenerative diseases.

We are committed to advancing drug development and pioneering scientific research to drive meaningful breakthroughs in neurodegenerative disease treatment.

Strategic Focus:  Support early-stage therapeutic development and translational research in academia and biotech through a venture philanthropy model that catalyzes innovation and de-risks follow-on investment.

Our Partners

Beneficiaries.

Alzheimer’s Drug Discovery Foundation

Gladstone

Therini

UCSD

Directly-Funded Projects.

Dr. Katerina Akassoglou Gladstone Institutes

Developing cell immunotherapies for neurodegenerative diseases
Initiated: 2021
Duration: 18 months

Dr. Tatiana Hurtado de Mendoza UCSD

Targeting neoantigens to pancreatic tumors to enable immunotherapy
Initiated: 2021
Duration: 3 years

Dr. Gianvito Martino San Raffaele Hospital with The International Progressive MS Alliance

Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis
Initiated: 2018
Duration: 4 years